Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...

Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...

DevOps and CSV form a powerful duo that, with strategic implementation, promises to propel the pharmaceutical industry.

Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...

Zenas BioPharma, Inc. ("Zenas” or the "Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...

Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...

Philly patients worry about affording their weight-loss medications as some insurers tighten requirements around coverage.

Microsoft, Amazon and Google are investing billions of dollars in a practical quantum system – an elusive technology that ...

Commercial property owner Sheldon Jackson has become perhaps the loudest anti-progressive voice in Spokane, rallying a following almost entirely by email.